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Background: Both experimental and clinical studies suggest that oxidative stress plays a major role in the
pathogenesis of both types of diabetes mellitus. This oxidative stress leads to β-cell destruction by apoptosis. Hence
exploring agents modulating oxidative stress is an effective strategy in the treatment of both Type I and Type II
diabetes. Plants are a major source of anti-oxidants and exert protective effects against oxidative stress in biological
systems. Phyllanthus emblica, Curcuma longa and Tinospora cordifolia are three such plants widely used in Ayurveda
for their anti-hyperglycemic activity. Additionally their anti-oxidant properties have been scientifically validated in
various experimental in vitro and in vivo models. Hence the present in vitro study was planned to assess whether
the anti-hyperglycemic effects of the hydro-alcoholic extracts of Phyllanthus emblica (Pe) and Curcuma longa (Cl)
and aqueous extract of Tinospora cordifolia (Tc) are mediated through their antioxidant and/or anti-apoptotic
property in a streptozotocin induced stress model.
Methods: RINm5F cell line was used as a model of pancreatic β-cells against stress induced by streptozotocin
(2 mM). Non-toxic concentrations of the plant extracts were identified using MTT assay. Lipid peroxidation through
MDA release, modulation of apoptosis and insulin release were the variables measured to assess streptozotocin
induced damage and protection afforded by the plant extracts.
Results: All 3 plants extracts significantly inhibited MDA release from RIN cells indicating protective effect against
STZ induced oxidative damage. They also exhibited a dose dependent anti-apoptotic effect as seen by a decrease
in the sub G0 population in response to STZ. None of the plant extracts affected insulin secretion from the cells to
a great extent.
Conclusion: The present study thus demonstrated that the protective effect of the selected medicinal plants
against oxidative stress induced by STZ in vitro, which was exerted through their anti-oxidant and anti-apoptotic
actions.
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Diabetes mellitus is a complex metabolic disorder resulting
from either insulin insufficiency or insulin dysfunction.
Type I diabetes (insulin dependent), is distinguishable by
selective destruction, via an autoimmune process, of the
insulin-secreting β-cell in the pancreatic islets of Langerhans,
and pancreatic β-cells are thought to be destroyed by apo-
ptotic death [1]. Type II diabetes or non-insulin-dependent
diabetes mellitus (NIDDM), is characterized by insulin re-
sistance, in which the primary insulin target organs (adi-
pose, muscle, and liver tissues) are poorly responsive to
insulin action and which may be combined with reduced
insulin secretion caused by a progressive loss of β-cell
function [2]. Oxidative stress plays a major role in the
pathogenesis of both types of diabetes mellitus [3]. Previ-
ous pre-clinical and clinical studies have demonstrated
that the elevation of reactive oxygen species (ROS) due to
oxidative stress is associated with decreased antioxidant
capacity in the islet β-cells in type 1 and type 2 diabetic
subjects [4,5]. The pancreatic β-cells are susceptible to
oxidative stress leading to cell apoptosis and consequent
insulin secretion reduction [6,7]. Hence evaluating agents
that modulate oxidative stress is an essential step for the
future development of therapeutic strategies for both Type
I and Type II diabetes.
Antioxidants, both exogenous and endogenous, whether
synthetic or natural, can be effective in prevention of oxi-
dative stress and protection of β-cell loss. Plants have been
suggested as the major source of anti-oxidants and are
capable of exerting protective effects against oxidative
stress in biological systems [8]. Phyllanthus emblica,
Curcuma longa and Tinospora cordifolia are three such
plants that are widely used in Ayurveda for their anti-
hyperglycemic activity and their anti-oxidant properties
have been scientifically validated in various experimen-
tal in vitro and in vivo models [9-14].
The present study was thus conducted to evaluate the
protective effect of the selected medicinal plants against
the oxidative stress induced by streptzotocin (STZ) using
RINm5F cells. RINm5F cell line is insulin secreting pan-
creatic beta cell line widely used as an alternative model
instead of animals to screen agents for anti-diabetic effects
of plants and β-cell dysfunction. STZ acts on β-cells by
generation of various ROS and act partially through oxi-
dative stress to induce β-cell apoptosis that leads to the
loss of β-cell mass and activation of [poly (ADP-ribose)
polymerase (PARP) leading to decrease in insulin secre-
tion [15,16].
The effect of plants on the oxidative stress was evalua-
ted using variables like lipid peroxidation in terms of
Malondialdehyde (MDA) release, modulation of apoptosis
and insulin release depending on the mechanism of action
of STZ (to assess the damage induced by streptozotocin).
Glibenclamide, a known anti-diabetic agent was used as apositive control to compare the effect of plants. Through
this study an attempt was also made to evaluate whether
anti-hyperglycemic activity exhibited by these plants is
mediated through their antioxidant and/or anti-apoptotic
property. This will facilitate in exploring the mechanistic
activity of the selected plants which will open up avenues
for development of these plants as anti-diabetic agents.
Methods
Materials
All chemicals were purchased from Sigma (St Louis, MO,
USA) and all culture media, serum supplements and anti-
biotic mixture solutions were purchased from Gibco BRL
Life Technologies Inc. (Carlsbad, CA, USA) unless other-
wise indicated.
Study drugs
Standardized hydroalcoholic extracts of Phyllanthus emblica
(fruits) and Curcuma longa (roots) and aqueous extract of
Tinospora cordifolia (stem) in powder form were procured
from Natural Remedies, Bangalore. The authentication re-
port and Certificate of analysis is available on file. Pure
powder of Glibenclamide was obtained as a gift from
Glenmark Pharmaceuticals, Mumbai.
The plant extracts were evaluated over a concentration
range from 2.5 to 100 μg/ml. These concentrations were
calculated from the therapeutic dose of the plants and
were within the concentration range commonly used for
in vitro studies. Glibenclamide was evaluated at a dose
of 1 μg/ml; dose extrapolated from the median thera-
peutic human dose.
The extracts of Phyllanthus emblica and Tinospora
cordifolia were dissolved in RPMI, cell culture medium
and diluted further. Curcuma longa and the standard drug
was first dissolved in DMSO and then reconstituted in cell
culture medium to achieve the required concentration.
The concentration of DMSO in the extract and standard
drug did not exceed 0.2%, which had no effect on the
obtained results.
Cell culture
A rat insulinoma cell line (RINm5F) was purchased from
National Centre for Cell Sciences, Pune and maintained
at 37°C under a humidified, 5% CO2 atmosphere in
RPMI-1640 medium supplemented with 10% fetal bo-
vine serum, 100 units/ml of penicillin, and 100 μg/ml of
streptomycin, and the medium was changed every two
days. Cells from passages 20–60 were used.
Methodology
Cell viability assay Viability of RINm5F cells after
treatment with the plant extracts and standard drug was
determined by assaying for the reduction of 3-(4,5-
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(MTT) to formazan. Briefly, cells were seeded in 96-well
plates (1 × 104 cells per well in 200 μl of medium
followed by treatment with different concentrations
(2.5, 5,10,25,50 and 100 μg/ml) of the selected plant
extracts. The plate was incubated for 24 hrs at 37°C with
5% CO2. Following incubation, MTT was added for 4 h
followed by the addition of HCl:Isopropanol (1:24) to
lyse the cells and solubilize the formazan crystals. The
absorbance of the resulting solution was read using an
ELISA plate reader (Biorad Laboratories Pvt Ltd., India)
at a wavelength of 570 nm. The amount of color pro-
duced was directly proportional to the number of viable
cells. Concentrations of the extracts that did not affect
cell viability were selected for further experiments.
Assay procedure RINm5F cells were grown in RPMI-
1640 medium supplemented with 10% FBS, in a humidi-
fied atmosphere of 5% CO2 at 37°C. On attaining 75-80%
confluency, the cells, at a concentration of 1 × 106cells/
ml, were loaded in a 24 well plate. The cells were then
treated with different concentrations of plant extracts
selected from viability study and standard anti-diabetic
drug in presence/absence of STZ (2 mM). Untreated
cells served as control. The plate was then incubated
for 24 hrs at 37°C in presence of 5% CO2. At the end
of incubation, effect of the plants against STZ induced
oxidative stress was assessed on the select variables.
Measurement of lipid peroxidation Lipid peroxidation
was measured in terms of levels of malondialdehyde (MDA)
expressed as nmole/mg of protein of the cell suspension.
After the incubation levels (MDA) were measured by
Thiobarbituric acid method [17].RINm5F cells were re
suspended in 0.5 ml of ice-cold Phosphate Buffered Saline
(PBS) and sonicated for 30 seconds. The assay mixture
contained 1 ml of 0.5 M KCl in 10 mM Tris HCl and
0.5 ml of 52 mM Thiobarbituric acid (TBA). The assay
mixture was then heated to 80°C for 30 mins and after
cooling to 0°C was centrifuged at 800×g for 10 minutes.
The absorbance of the supernatant was measured at
532 nm using a dual beam spectrophotometer (Analytika
Jena, Germany). The levels of MDA was calculated based
on standard curve constructed with 1,13,3- tetra ethoxy
propane. Cell protein was estimated using Folin Lowry
method and extrapolated from standard curve constructed
with Bovine Serum Albumin (BSA).
Measurement of apoptosis The degree of apoptosis
was determined using Propidium iodide (PI) stain which
intercalates into double stranded nucleic acids that can
be excited by 488 nm lasers [18]. The cells, subjected to
treatment were lysed using a lysis buffer containing Tris
HCl (100 mM), NaCl (154 mM), CaCl2 (1 mM), MgCl2(0.5 mM) and 0.1% NP 40. Propidium iodide (50 μg/ml)
was added to the lysing solution to stain the cells. RNAse
(40 μg/ml) was also added, as PI is known to intercalate
with RNA. The lysing solution containing the cells was
then incubated in dark at room temperature for 30 minutes
and the fluorescent intensity was measured using a FAC-
Scan (Becton Dickinson, San Jose, CA).
Measurement of insulin secretion The supernatant of
the cells after each incubation was collected and used to
measure the insulin secretion using a Rat Insulin Elisa
kit (Mercodia, Sweden).
Statistical analysis The results were analyzed for statis-
tical significance by one-way analysis of variance (ANOVA)
test followed by Tukey‘s post hoc test using the Graphpad
Instat software (version 3.06). All data was expressed as
Mean ± SD values. In all analyses, a p value of <0.05 was
considered statistically significant.
Results & discussion
A number of medicinal plants have been used to control
blood glucose and to either inhibit or trigger fundamen-
tal cellular processes mainly through their anti-oxidant
potential, making oxidative stress and apoptosis acquies-
cent to pharmacological intervention [19].In our study, we
evaluated the protective effect of the selected medicinal
plants to modulate the oxidative stress and apoptosis
which are the major contributors to diabetes mellitus de-
velopment. Furthermore, the effect of plants on the modu-
lation of insulin release was also studied.
Prior to evaluating the effect of plants, viability studies
were carried out. The viability studies help in eliminat-
ing the cytotoxic doses of plant extracts and thereby de-
termining out the precise range of concentrations of the
extracts for further experiments. The viability of RINm5F
cells after treatment with the plant extracts was assayed
by the MTT assay over a concentration range of 2.5 to
100 μg/ml. On evaluating the MTT results, it was ob-
served that, Phyllanthus emblica and Tinospora cordifolia
did not affect the viability of RIN cells up to 100 μg/ml,
whereas Curcuma longa affected viability at higher con-
centration. Hence efficacy studies were carried out using a
concentration range of 2.5 to 100 μg/ml for Phyllanthus
emblica and Tinospora cordifolia and 50 μg/ml for Cur-
cuma longa.
Following viability study, the effect of plant extracts was
evaluated on the select variables based on therapeutic
interest to assess the anti-oxidant, anti-apoptotic and
insulin secretagogue effect of the plant extracts.
Effect on lipid peroxidation
The first variable estimated was effect on lipid peroxida-
tion in terms of MDA release to assess the anti-oxidant
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The effect of plants per se on MDA release to assess the
anti-oxidant potential of the plants was initially studied.
As seen in Figure 1A, Phyllanthus emblica showed a dose
dependent increase in MDA levels as compared to the
control RIN cells. Curcuma longa showed a significant
dose dependent decrease in MDA levels as compared to
control cells demonstrating its anti-oxidant potential
(Figure 1C). These results are in agreement with re-
ported literature that Curcuma longa exhibits anti-
oxidant activity [20].Tinospora cordifolia per se showed
no effect on the MDA release (Figure 1E).
As expected, incubation of RIN cells with 2 mM STZ
caused a significant increase in MDA levels as compared
to untreated cells demonstrating oxidative stress. However
in presence of STZ, Phyllanthus emblica showed a signifi-
cant decrease in MDA release at lower concentrations i.e.,
2.5 to 10 μg/ml showing protection to the RIN cells
against the stress induced per se by STZ (Figure 1B). This
effect was contrary to the effect exhibited by PhyllanthusFigure 1 Effect of selected medicinal plants on MDA release from RINemblica. This is probably reflective of the rasayana prop-
erty of Phyllanthus emblica. The property of enhancing
physiological conditions and restoring balance or equilib-
rium in pathological conditions is called a rasayana [21].
Phyllanthus emblica is one such plant which is said to be
a rasayana plant [22]. However the amount of protection
exhibited at higher concentrations was less as compared
to that seen with the lower concentrations.
Curcuma longa also demonstrated similar results as
compared to Phyllanthus emblica showing maximum
protection to RIN cells at 10 μg/ml against the stress in-
duced by STZ (Figure 1D). Tinospora cordifolia showed
a dose dependent decrease in MDA release in STZ
treated RIN cells at all the concentrations tested with
the maximum decrease seen at the highest concentration
tested (Figure 1F). Although Tinospora cordifolia too is a
rasayana plant, unlike Phyllantus emblica, it showed no
effect per se on MDA release in untreated RIN cells. It
however protected against the oxidative stress induced
by STZ by demonstrating a decrease in MDA levels. Thism5F cells in the absence (A,B,C) and presence (D,E,F) of STZ.
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may be due to the type of extract used in the study. The
increase in MDA levels at higher doses of Phyllantus
emblica per se or in presence of STZ may be due to the
presence of polar substances in the hydro-alcoholic
extracts of Phyllantus emblica, which interfered with the
anti-oxidant effect thus affecting the degree of protection.
The results of our study also highlight the fact that Ayur-
veda recommends the use of decoction of plant extracts
prepared in water for better activity. Glibenclamide used
as the standard in the assay showed an increase in MDA
release per se and also in the presence of STZ. Similar in-
crease in MDA levels has also been reported in a previous
study wherein MDA levels from the tissues of diabetic rats
treated with Glibenclamide was estimated [23]. Although
there are reports of the antioxidant effects of sulfonylureas
in diabetic subjects, the effect is more prominent with
glipizide than with Glibenclamide [24-26].
Effect on apoptosis
The second variable studied was the potential of these
plants to modulate apoptosis. It is reported that DNA
fragmentation is a characteristic pattern of apoptotic cell
death in various cell types, including β-cell lines [27-29].
RIN cells treated with the plant extracts in presence/
absence of STZ were subjected to PI staining and run on
a Flow cytometer to detect apoptosis using Cell Cycle
analysis. As seen in Table 1 and Figure 2, STZ induced
apoptosis as observed as a significant increase in the sub
G0 (apoptotic) population marked as M1 (25.48 ± 3.77)
as compared to untreated RIN cells (8.18 ± 1.41) in the
histogram with a subsequent decrease in G0/G1 popula-
tion marked as M2 (39.13 ± 6.69) as against the un-
treated RIN cells (52.46 ± 6.99).
In the absence of STZ, Phyllanthus emblica increased
the number of cells in the sub G0 (apoptotic) cell popu-
lation as compared to untreated control, indicating beta
cell damage. However, when administered in the pres-
ence of STZ, Phyllanthus emblica protected the RIN
cells against STZ induced damage (25.48 ± 3.77), with a
dose dependent effect with maximum and significant
protection at 10 μg/ml (11.77 ±2.31) subsequently in-
creasing number of cells in G0/G1 population marked as
M2 (45.28 ±5.61) as against the STZ treated RIN cells
(39.13 ±6.69). Higher concentrations showed protection
but to a lesser extent. The results once again confirmed
the rasayana property of Phyllanthus emblica.
As reported in Table 1, incubation of RIN cells with
Curcuma longa (Cl) alone per se showed no effect in the
sub G0 (apoptotic) population as compared to the con-
trol RIN cells. However, when combined with STZ treat-
ment, it showed a decrease in the sub G0 (apoptotic)
cell population with maximum effect at 10 μg/ml (10.94 ±
3.78) as compared to the cells treated with STZ alone(23.37 ± 4.51). Thus, it appeared to protect the RIN cells
against the damage induced by STZ by increasing the
number of cells in G0/G1 population marked as M2
(51.75 ± 5.09) as against the STZ treated RIN cells
(44.60 ± 3.09).
Treatment of RINm5F cells with Tinospora cordifolia
alone did not affect the number of cells in the sub G0
(apoptotic) population except at 100 μg/ml wherein an
increase in sub G0 (apoptotic) cell population was ob-
served. Tinospora cordifolia also demonstrated a signifi-
cant dose dependent decrease in the sub G0 (apoptotic)
population with maximum effect at 100 μg/ml (14.05 ±
1.80) when administrated in the presence of STZ indi-
cating protection against the damage induced by STZ
(24.69 ± 2.19) subsequently increasing the cells in G0/G1
population marked as M2 (48.64 ± 1.3) as against the
STZ treated RIN cells (40.01 ± 9.17). Results shown in
Table 1.
The effect of all plants were comparable to Glibencla-
mide which also exhibited protection against the apoptotic
damage induced by STZ by decreasing the sub G0 (apop-
totic) cell population (19.91 ± 5.05 vs. 28.5 ± 8.85) and sub-
sequently increasing the number of cells in G0/G1
population marked as M2 (53.22 ±11.81) as against the
STZ treated RIN cells (40.24 ±6.71). These results are
contrary to that seen in previous studies wherein
Glibenclamide has been shown to induce apoptosis in
pancreatic beta-cells or beta-cell lines under certain condi-
tions [30]. Our explanation for the results obtained in our
study is that this may be due to the difference in dose used
and the time of exposure which could have influenced the
action of Glibenclamide which needs to be explored
further.
Effect on insulin secretion
The effect of drugs on insulin secretion was evaluated as
damaged pancreatic beta cells lose their capacity to secrete
insulin. Phyllanthus emblica per se showed no effect on
insulin secretion as compared to the untreated cells. How-
ever in presence of STZ, it showed an increase in insulin
secretion at 10 μg/ml. This concentration is the same at
which maximum anti-oxidant and anti-apoptotic effect of
Phyllanthus emblica was observed. Curcuma longa (Cl)
per se and in presence of STZ demonstrated a decrease in
insulin secretion as compared to the untreated cells. These
results emphasize the fact that Curcuma longa may have
an effect on activation of Poly ADP ribosylation which
play a role in inhibiting insulin secretion [31]. Tinospora
cordifolia (Tc) per se increased insulin release as compared
to the untreated cells. In presence of STZ, an increase in
insulin release was observed at higher concentration i.e.,
100 μg/ml however the effect was not significant.
Glibenclamide per se showed an increase in insulin secre-
tion and also increased the insulin release from STZ
Table 1 Effect of selected medicinal plants on apoptosis induced by STZ in RINm5F cells
Groups under study % Cells in Pre G1 (M1) % Cells in G0, G1 (M2) % Cells in G2,M,S (M3)
Cell control 8.18 ± 1.41 52.46 ±6.99 26.419 ±2.56
Cells + Pe (2.5 μg/ml) 11.81 ±2.98 52.03 ±17.41 27.51 ± 9.19
Cells + Pe (5 μg/ml) 11.51 ±2.98 51.25 ±3.22 27.75 ±3.53
Cells + Pe (10 μg/ml) 16.03 ±4.52* 48.01 ±8.50 25.60 ±4.66
Cells + Pe (25 μg/ml) 17.39 ±1.82 49.05 ±5.53 25.97 ±1.96
Cells + Pe (50 μg/ml) 18.33 ±1.62* 45.79 ±3.17 28.47 ±1.99
Cells + Pe (100 μg/ml) 20.63 ±1.60*** 44.01 ±2.35 26.29 ±1.58
Cells + STZ 25.48 ± 3.77*** 39.13 ±6.69* 36.18 ±8.48
Cells + Pe (2.5 μg/ml) + STZ 19.25 ±3.45 41.25 ±6.69 31.02 ±8.75
Cells + Pe (5 μg/ml) + STZ 15.29 ±4.05$$$ 37.86 ±6.77 34.75 ±8.34
Cells + Pe (10 μg/ml) + STZ 11.77 ±2.31$$$ 45.28 ±5.61 29.13 ±7.98
Cells + Pe (25 μg/ml) + STZ 16.04 ±1.42$$$ 38.65 ±3.43 35.40 ±2.99
Cells + Pe (50 μg/ml) + STZ 18.34 ±1.23$ 36.89 ±4.33 29.86 ±5.26
Cells + Pe (100 μg/ml) + STZ 23.35 ±1.80 36.90 ±4.15 30.29 ±4.29
Cell control 9.58 ± 2.48 56.03 ± 2.65 25.51 ± 2.05
Cells + Cl (2.5 μg/ml) 11.05 ± 2.89 51.28 ± 3.32 26.82 ± 4.27
Cells + Cl (5 μg/ml) 10.36 ± 3.94 51.24 ± 2.88 28.41 ± 3.41
Cells + Cl (10 μg/ml) 10.94 ± 3.78 51.75 ± 5.09 28.81 ± 4.81
Cells + Cl (25 μg/ml) 12.98 ± 2.72 46.02 ± 7.77 30.61 ± 1.71
Cells + Cl (50 μg/ml) 14.7 ± 2.06 48.61 ± 4.63 31.94 ± 2.61
Cells + STZ 23.37 ± 4.51*** 41.38 ± 7.44 32.21 ± 6.86
Cells + Cl (2.5 μg/ml) + STZ 17.14 ± 4.75$$ 41.94 ± 5.02 31.21 ± 8.91
Cells + Cl (5 μg/ml) + STZ 15.77 ± 5.13$$$ 40.82 ± 2.87 32.73 ± 7.59
Cells + Cl (10 μg/ml) + STZ 12.74 ± 3.07$$ 44.60 ± 3.09 29.62 ± 7.73
Cells + Cl(25 μg/ml) + STZ 18.74 ± 2.44 42.42 ± 1.93 35.47 ± 1.38
Cells + Cl (50 μg/ml) + STZ 19.13 ± 3.99 40.18 ± 3.48 32.40 ± 1.67
Cell control 5.87 ± 1.70 53.22 ± 11.81 26.98 ± 7.17
Cells + Tc 2.5 μg/ml 7 ± 1.57 57.79 ± 13.81 23.90 ± 6.57
Cells + Tc 5 μg/ml 5.92 ± 1.91 59.32 ± 13.48 23.98 ± 7.96
Cells + Tc 10 μg/ml 7.12 ± 2.22 57.12 ± 12.35 24.58 ± 7.44
Cells + Tc 25 μg/ml 7.62 ± 2.17 57.13 ± 3.45 25.73 ± 6.11
Cells + Tc 50 μg/ml 7.07 ± 2.44 60.44 ± 3.89 20.03 ± 5.79
Cells + Tc100 μg/ml 10.16 ± 5.27 56.95 ± 2.47 28.68 ± 0.69
Cells + STZ 24.69 ± 2.19*** 40.01 ± 9.17* 26.28 ± 1.67
Cells + Tc2.5 μg/ml + STZ 26.69 ± 1.34 51.35 ± 6.22 18.73 ± 8.09
Cells + Tc 5 μg/ml + STZ 25.86 ± 1.83 35.08 ± 10.81 34.82 ± 6.61
Cells + Tc 10 μg/ml + STZ 21.65 ± 3.34 43.86 ± 9.22 25.21 ± 8.91
Cells + Tc 25 μg/ml + STZ 16.77 ± 3.65$$ 43.48 ± 2.13 31.36 ± 3.86
Cells + Tc 50 μg/ml + STZ 14.16 ± 1.69$ 42.86 ± 6.94 28.54 ± 6.12
Cells + Tc100 μg/ml + STZ 14.05 ± 1.80$$ 48.64 ± 1.3 36.12 ± 1.78
Cell control 11.87 ± 3.70 53.22 ± 11.81 26.98 ± 7.17
Cells + Gb (1 μg/ml) 12.6 ± 2.39 49.79 ± 9.11 26.87 ± 6.33
Cells + STZ 28.5 ± 8.85*** 40.24 ± 6.71* 28.42 ± 8.30
Cells + STZ + Gb (1 μg/ml) 19.91 ± 5.05$ 47.3 ± 5.92 25.84 ± 3.12
RINm5F cells were treated with different concentrations of plants extracts in presence and absence of STZ. Apoptosis was measured using cell cycle analysis from
the DNA histograms generated on the Flow Cytometer followed by PI staining. All values are indicative of Mean ± SD. *p < 0.05;***p < 0.001 as compared to
Untreated cells, $p < 0.05; $$p < 0.01; $$$p < 0.001 as compared to STZ treated cells. (ANOVA followed by post hoc test).
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Figure 2 DNA Histograms of RINm5F cells treated with selected plants in presence and absence of STZ. RINm5F cells were treated with
different concentrations of plants extracts in presence and absence of STZ. Apoptosis was measured using cell cycle analysis from the DNA
histograms generated on the Flow Cytometer followed by PI staining. All values are indicative of Mean ± SD. **p < 0.01;***p < 0.001 as compared
to Untreated cells, $p < 0.05; $$p < 0.01; as compared to STZ untreated cells. (ANOVA followed by post hoc test).
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mainly by stimulating the cells in the pancreas that pro-
duce insulin. The results are represented in Figures 3, 4
and 5.Figure 3 Effect of Phyllanthus emblica on Insulin release from
RINm5F cells in presence and absence of STZ.The results of MDA release demonstrate the protective
effect of the plants against the oxidative stress induced by
STZ once again confirming the reported anti-oxidant po-
tential of the plants thereby strengthening the evidence
that these plants can be used to reduce the oxidative stress
generated in diabetes and further help in delaying the
development of diabetic complications.
Hydro-alcoholic extract of Phyllanthus emblica consists
of presence of phyto-constituents viz., alkaloids, glyco-
sides, reducing sugars, tannins, resins, saponins, sterols
and fixed oils. Vitamin C, the major phyto-constituent of
Phyllanthus emblica is a known anti-oxidant [32]. Hence
we can say that Vitamin C may contribute to the anti-
oxidant activity noted in terms of lipid peroxidation
exhibited by Phyllanthus emblica. Gallic acid and Ellagic
acid, which are well-known natural antioxidants forms the
major phyto-constituents of Phyllanthus emblica. Gallic
acid has been reported to possess anti-apoptotic and insu-
lin secretagogue activity in RINmF cells [33]. Ellagic acid
Figure 4 Effect of Curcuma longa on Insulin release from
RINm5F cells in presence and absence of STZ.
Kalekar et al. BMC Complementary and Alternative Medicine 2013, 13:257 Page 8 of 9
http://www.biomedcentral.com/1472-6882/13/257is also reported to exhibit both antioxidant activity in
V79-4 cells and apoptosis-inducing activity in HOS cells
[34]. Thus the anti-oxidant and anti-apoptotic activity
possessed by Phyllanthus emblica may be due to the pres-
ence of Gallic acid and Ellagic acid. Curcumin, the major
active constituent present in hydro-alcoholic extract of
Curcuma longa, exhibits anti-oxidant as well as anti-
apoptotic activity [35,36]. Thus, we can conclude that the
anti-apopototic and anti-oxidant effect shown by Curcuma
longa may be attributed to the presence of Curcumin.
Alkaloids, tannins, cardiac glycosides, flavonoids, saponins,
and steroids as the major phyto-constituents [37] of
Tinospora cordifolia have been reported to play an anti-
diabetic role. Alkaloids like Berberine are reported to
have anti-oxidant and anti-apoptotic activity [38,39].
Glycosides like Tinocordiside and Tinocordifolioside
have been reported to have anti-oxidant and hydroxyl
radical scavenging activities in Swiss albino mice [40].
Hence the anti-oxidant and anti-apoptotic activity
exhibited by Tinospora cordifolia in our study may be
due to the presence of these constituents.
The data on cell cycle analysis clearly revealed the role
of STZ as an apoptotic agent, and the effect seen with the
plant extracts revealed the role of plants as anti-apoptotic
agents suggesting that the observed growth-inhibitoryFigure 5 Effect of Tinospora cordifolia on Insulin release from
RINm5F cells in presence and absence of STZ.effect of STZ in RIN cells could be ameliorated by
addition of these plants. Also the results of cell cycle ana-
lysis of all the plants were similar to the results of MDA
release demonstrating that the anti-oxidant potential
exhibited by the plant extracts facilitated the protection
against the oxidative stress induced by STZ.
From the above results the probable mechanism of action
of Curcuma longa and Tinospora cordifolia may be through
their anti-oxidant potential which was confirmed in our
study through their ability to decrease lipid peroxidation in
the presence of STZ thus showing protection against the
induced oxidative damage. Although Phyllanthus emblica
per se showed an increase in lipid peroxidation it protected
the RIN cells against the damage induced by STZ proving
its rasayana property. The second mode of anti-diabetic ac-
tion may be through its anti-apoptotic effect as seen by the
protection offered by Phyllanthus emblica, Curcuma longa
and Tinospora cordifolia in abrogating apoptosis induced
by STZ resulting in a cytogram with similar profile to con-
trol cells. Their anti-apoptotic action can help in preserva-
tion of the residual β-cell mass with minimal effect seen
on insulin secretion. The importance of the progressive
loss of pancreatic β-cell reduction in the course of type 2
Diabetes has been the focus of therapeutic targets in the
development of novel and potential drugs acting by en-
hancing pancreatic β-cell growth and/or survival. Thus
prolonged administration of these plants may expand pan-
creatic β-cell mass, leading to increased insulin secretion
and improved glycemic control. These plants may thus
have a beneficial effect in diabetic individuals through
their anti-oxidant and anti-apoptotic actions.
Although the study reveals the mechanism of action of
the selected plants it is essential to further elucidate the
underlying molecular mechanism for the anti-diabetic ac-
tion using in vivo models of diabetes and its associated
complications. Also isolation and identification of active
constituents from these plants, preparation and standar-
dization of the dose, pharmacological and toxicological
evaluation of the active principle will help in developing
these plants into potential anti-diabetic drugs which after
clinical assessment can be incorporated in the anti dia-
betic drug armamentarium.Conclusion
The present study confirms the protective effect of the
selected medicinal plants against the oxidative damage
induced by STZ. This is the first study to reveal the anti-
diabetic mechanistic actions of Phyllanthus emblica, Cur-
cuma longa and Tinospora cordifolia which is exerted
through their anti-oxidant and anti-apoptotic potential.Competing interests
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